Three-quarters of pharma and life sciences executives said they were optimistic for 2025, even though they expect some level ...

Sai Life Sciences' IPO saw an 84% subscription rate on its first day. Institutional investors showed strong interest. The IPO ...

Valuations of life sciences businesses declined in the wake of the global pandemic, but government stimulus and medical ...

Many VCs, particularly newer firms, readily admit that 2024 has been a challenging year for raising fresh capital. Dimension ...

In an exclusive interview, an expert in Unispace's Life Sciences growth strategy across the Americas, offers his perspective ...

Sai Life Sciences IPO opens for public subscription today, Wednesday, December 11, 2024, and will close on Friday, December ...

The proposed initial public offering includes a new issuance of equity shares amounting to ₹ 950 crore, along with an offer ...

Valsoft Corporation Inc. (”Valsoft”), a Canadian company specializing in the acquisition and development of vertical market software businesses, has acquired Exeevo, a unified CRM solution for sales, ...

The Sai Life Sciences IPO, priced between ₹522 to ₹549, has opened for subscription. The IPO combines the new issuance of ...

Retail investors subscribed 8%, non-institutional investors 4%, while qualified institutional buyers made no bids yet for the ...

AHP, based in Wayne, Pennsylvania, is a lower middle market private equity investor focused exclusively on healthcare. A division of Argosy Capital, AHP typically pursues majority control transactions ...

The proposed initial public offering includes a new issuance of equity shares amounting to ₹ 950 crore, along with an offer ...